Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma

Riyad N H Seervai; Craig Y Okada; Stephanie J Mengden-Koon; Noah I Hornick

doi:10.1016/j.jdcr.2024.08.013

Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma

JAAD Case Rep. 2024 Sep 2:53:1-5. doi: 10.1016/j.jdcr.2024.08.013. eCollection 2024 Nov.

Authors

Riyad N H Seervai¹, Craig Y Okada², Stephanie J Mengden-Koon¹, Noah I Hornick¹

Affiliations

¹ Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
² Department of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.

No abstract available

Keywords: dermatologic toxicity; follicular lymphoma; interface dermatitis; loncastuximab tesirine; oncologic dermatology; vesiculobullous dermatitis.

Publication types

Case Reports